Trial
NCT03517995
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
National Institutes of Health (NIH); Johns Hopkins University
Condition
Bladder Cancer
Intervention
Sulforaphane Administration
Why stopped
Grant not approved
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-28